本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Vir Biotechnology, Inc.

5.58
-0.3800-6.38%
盘后5.580.00000.00%19:18 EDT
成交量:190.15万
成交额:1,062.76万
市值:7.65亿
市盈率:-1.46
高:5.85
开:5.81
低:5.49
收:5.96
数据加载中...
2025/04/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/26

重要事件披露

Form 8-K - Current report
2025/02/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/30

重要事件披露

Form 8-K - Current report
2025/01/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/08

重要事件披露

Form 8-K - Current report
2024/12/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/01

重要事件披露

Form 8-K - Current report